These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17465282)

  • 1. Sublingual immunotherapy: from safety to mechanism of action.
    Marcucci F; Sensi L; Allocca G; Chiarello F; Palleri P; Ugolini E; Di Rienzo A; Castellani S; Incorvaia C; Di Cara G; Puccinelli P; Frati F
    Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological mechanisms of sublingual allergen-specific immunotherapy.
    Novak N; Bieber T; Allam JP
    Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do we need to learn to optimize the SLIT alternative?
    Serra HM; Alignani DO; Passalacqua G; Canonica GW; Correa SG
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):158-65. PubMed ID: 17058848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy: the optimism and the issues.
    Pajno GB
    J Allergy Clin Immunol; 2007 Apr; 119(4):796-801. PubMed ID: 17306355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization application to allergic disease: sublingual immunotherapy.
    Frati F; Moingeon P; Marcucci F; Puccinelli P; Sensi L; Di Cara G; Incorvaia C
    Allergy Asthma Proc; 2007; 28(1):35-9. PubMed ID: 17390755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological mechanisms of sublingual immunotherapy.
    Akdis CA; Barlan IB; Bahceciler N; Akdis M
    Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local immunological mechanisms of sublingual immunotherapy.
    Allam JP; Novak N
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):571-8. PubMed ID: 22001742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual and oral immunotherapy.
    Canonica GW; Compalati E; Fumagalli F; Passalacqua G
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):685-704, vii. PubMed ID: 15474866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of sublingual immunotherapy.
    Marcucci F; Duse M; Frati F; Incorvaia C; Marseglia GL; La Rosa M
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):31-3. PubMed ID: 19944008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4.
    Piconi S; Trabattoni D; Rainone V; Borgonovo L; Passerini S; Rizzardini G; Frati F; Iemoli E; Clerici M
    J Immunol; 2010 Dec; 185(12):7723-30. PubMed ID: 21076061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bright future for sublingual immunotherapy--contra.
    Kleine-Tebbe J
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):242-50; discussion 250-2. PubMed ID: 17393746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual Immunotherapy: Past, present, paradigm for the future? A review of the literature.
    Leatherman BD; Owen S; Parker M; Chadwick S; Fornadley JA; Colson D; Fass P
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3 Suppl):S1-20. PubMed ID: 17321336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy: administration, dosages, use.
    Frati F; La Grutta S; Bernardini R; Zampogna S; Scurati S; Puccinelli P; Riario-Sforza GG; Incorvaia C
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):13-6. PubMed ID: 19944004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.
    Razafindratsita A; Saint-Lu N; Mascarell L; Berjont N; Bardon T; Betbeder D; Van Overtvelt L; Moingeon P
    J Allergy Clin Immunol; 2007 Aug; 120(2):278-85. PubMed ID: 17531296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.